期刊文献+

CT与MRI诊断原发性肝癌介入术后病灶残留及复发临床价值 被引量:5

Clinical Value of CT and MRI in the Diagnosis of Residual and Recurrent Primary Liver Cancer after Interventional Therapy
下载PDF
导出
摘要 目的:研究CT和MRI对原发性肝癌介入治疗后病灶残留及复发的诊断价值.方法:纳入90例患者作为此次研究的对象,纳入时间段为2018年3月-2019年1月,所有患者均在笔者所在医院确诊为原发性肝癌,均在笔者所在医院接受了介入术治疗,治疗6个月后对患者进行随访,分别对90例患者进行DSA(数字减影血管造影)检查、CT检查、MRI检查,以DSA检查结果作为此次研究的对照标准,分别将CT、MRI检查的结果与DSA的检查结果进行对比,评价CT、MRI对此类患者的诊断效果.结果:DSA检查54例(60.00%)患者存在病灶残留,42例(46.67%)患者出现复发.CT检查42例(46.67%)存在病灶残留(准确率、特异性、灵敏度分别为86.67%、100%、77.78%),35例(38.89%)出现复发(准确率、特异性、灵敏度分别为92.22%、100%、83.33%);MRI检查50例(55.56%)存在病灶残留(准确率、特异性、灵敏度分别为95.56%、100%、92.59%),41例(45.56%)出现复发(准确率、特异性、灵敏度分别为98.89%、100%、97.62);CT与MRI对病灶残留及复发诊断的特异性差异无统计学意义(P>0.05),但MRI对病灶残留及复发诊断的准确率及灵敏度均显著高于CT(P<0.05).结论:对原发性肝癌介入治疗后病灶残留及复发的诊断工作来说,MRI较CT有着更高的利用价值,对于病灶残留及复发诊断的准确率及灵敏度显著高于CT,因此,值得在临床上进行推广及应用. Objective:To study the diagnostic value of CT and MRI in residual and recurrence of primary hepatic cancer after interventional therapy.Method:Ninety patients were included in this study.They were diagnosed as primary hepatic carcinoma in our hospital from March 2018 to January 2019.All patients received interventional therapy in our hospital.After six months of treatment,the patients were followed up and 90 patients underwent DSA(digital subtraction angiography)examination,CT and MRI,DSA was used as the control criteria for this study.The results of CT and MRI were compared with those of DSA,and the diagnostic effects of CT and MRI were evaluated.Result:DSA results showed that 54 patients(60.00%)had residual lesions and 42 patients(46.67%)had recurrence.CT results showed that 42 patients(46.67%)had residual lesions(accuracy,specificity and sensitivity were 86.67%,100%,77.78%,respectively),and 35 patients(38.89%)had recurrence(accuracy,specificity and sensitivity were 92.22%,100%,83.33%).The results of MRI showed that 50 cases(55.56%)had residual lesions(accuracy,specificity and sensitivity were 95.56%,100%and 92.59%,respectively),and 41 cases(45.56%)had recurrence(accuracy,specificity and sensitivity were 98.89%,100%and 97.62%respectively).There was no statistical difference in the specificity of CT and MRI in diagnosis of residual and recurrent lesions(P>0.05),but the accuracy and sensitivity of MRI in diagnosis of residual and recurrent lesions were significantly higher than those of CT(P<0.05).Conclusion:For the diagnosis of residual and recurrence of primary hepatic carcinoma after interventional therapy,MRI is more valuable than CT.The accuracy and sensitivity of diagnosis of residual and recurrence of primary hepatic carcinoma are significantly higher than CT.Therefore,it is worth popularizing and applying in clinic.
作者 徐庆 邓凡 潘海松 XU Qing;DENG Fan;PAN Haisong(Hubei Traditional Chinese Medicine Hospital,Wuhan 430074,China)
出处 《中外医学研究》 2020年第2期67-69,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 MRI CT 原发性肝癌 介入治疗 病灶残留 复发诊断 MRI CT Primary hepatic carcinoma Interventional therapy Focal residual Recurrent diagnosis
  • 相关文献

参考文献9

二级参考文献62

共引文献191

同被引文献47

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部